“…Based on this consideration we designed 12 single mutants namely: W180F, W180L, W241F, W241L, W278F, W278L, W332F, W332L, F334L, W337F, W337L, Y516L. These mutants in human TG2 have not yet been purposefully created for the characterisation of their isopeptidase property (Murthy et al 2002, Iismaa et al 2003.…”